ResearchMoz

Singapore Medical Tourism Analysis and Forecast

Renub Research
Published Date » 2014-04-09
No. Of Pages » 74
 Singapore is one of the top medical tourist destinations in the world. With modern medical technology and highly trained doctors Singapore private hospitals offer exceptional health care services. Patients from all over the world visit to Singapore for treatment because Singapore has a team of high standard medical expertise along with many well known tourist attractions to explore. Singapore Tourism Board (STB) works closely with the private healthcare providers to strengthen and expand their reach and referral networks in key target markets. In addition, STB facilitates industry development capabilities to create and deliver value-added experiences so as to enhance service delivery for greater patient satisfaction. At the same time, STB continues to partner the private industry to...
Table of Content

1. Executive Summary

2. Singapore Medical Tourists Arrivals

3. Singapore Medical Tourism Market & Forecast

4. Singapore Medical Tourism – Country Wise Medical Tourists Arrivals, Spending & Forecast
4.1 United States – Medical Tourists Arrivals, Spending & Forecast
4.1.1 United States – Medical Tourists Arrivals & Forecast (2004 - 2018) 
4.1.2 United States – Medical Tourists Spending & Forecast (2004 - 2018) 
4.2 Canada – Medical Tourists Arrivals, Spending & Forecast
4.2.1 Canada – Medical Tourists Arrivals (2004 - 2008) 
4.2.2 Canada – Medical Tourists Spending (2004 - 2008) 
4.3 Indonesia – Medical Tourists Arrivals, Spending & Forecast
4.3.1 Indonesia – Medical Tourists Arrivals & Forecast (2004 - 2018) 
4.3.2 Indonesia – Medical Tourists Spending & Forecast (2004 - 2018) 
4.4 Malaysia – Medical Tourists Arrivals, Spending & Forecast
4.4.1 Malaysia – Medical Tourists Arrivals & Forecast (2004 - 2018) 
4.4.2 Malaysia – Medical Tourists Spending & Forecast (2004 - 2018) 
4.5 Philippines – Medical Tourists Arrivals, Spending & Forecast
4.5.1 Philippines – Medical Tourists Arrivals & Forecast (2005 - 2018) 
4.5.2 Philippines – Medical Tourists Spending & Forecast (2005 - 2018) 
4.6 Thailand – Medical Tourists Arrivals, Spending & Forecast
4.6.1 Thailand – Medical Tourists Arrivals & Forecast (2004 - 2018) 
4.6.2 Thailand – Medical Tourists Spending & Forecast (2004 - 2018) 
4.7 China – Medical Tourists Arrivals, Spending & Forecast 
4.7.1 China – Medical Tourists Arrivals & Forecast (2004 - 2018) 
4.7.2 China – Medical Tourists Spending & Forecast (2004 - 2018) 
4.8 Taiwan – Medical Tourists Arrivals, Spending & Forecast
4.8.1 Taiwan – Medical Tourists Arrivals & Forecast (2004 - 2018) 
4.8.2 Taiwan – Medical Tourists Spending & Forecast (2004 - 2018) 
4.9 Hong Kong – Medical Tourists Arrivals, Spending & Forecast
4.9.1 Hong Kong – Medical Tourists Arrivals & Forecast (2006 - 2018) 
4.9.2 Hong Kong – Medical Tourists Spending & Forecast (2006 - 2018) 
4.10 South Korea – Medical Tourists Arrivals, Spending
4.10.1 South Korea – Medical Tourists Arrivals (2004 & 2009) 
4.10.2 South Korea – Medical Tourists Spending (2004 & 2009) 
4.11 India – Medical Tourists Arrivals, Spending & Forecast
4.11.1 India – Medical Tourists Arrivals & Forecast (2004 - 2018) 
4.11.2 India – Medical Tourists Spending & Forecast (2004 - 2018) 
4.12 Netherlands – Medical Tourists Arrivals, Spending
4.12.1 Netherlands – Medical Tourists Arrivals (2006 & 2009) 
4.12.2 Netherlands – Medical Tourists Spending & Forecast (2006 & 2009) 
4.13 United Kingdom – Medical Tourists Arrivals, Spending & Forecast
4.13.1 United Kingdom – Medical Tourists Arrivals & Forecast (2005 - 2018) 
4.13.2 UK – Medical Tourists Spending & Forecast (2005 - 2018) 
4.14 Australia – Medical Tourists Arrivals, Spending & Forecast
4.14.1 Australia – Medical Tourists Arrivals & Forecast (2004 - 2018) 
4.14.2 Australia – Medical Tourists Spending & Forecast (2004 - 2018) 
4.15 Africa – Medical Tourists Arrivals, Spending & Forecast
4.15.1 Africa – Medical Tourists Arrivals & Forecast (2006 - 2018) 
4.15.2 Africa – Medical Tourists Spending & Forecast (2006 - 2018) 
4.16 Other Countries – Medical Tourists Arrivals, Spending & Forecast
4.16.1 Other Countries – Medical Tourists Arrivals & Forecast (2006 - 2018) 
4.16.2 Other Countries – Medical Tourists Spending & Forecast (2006 - 2018) 

List of Tables


List of Figures

Figure 2 1: Singapore – Medical Tourists Arrivals (Number), 2004 – 2013
Figure 2 2: Singapore – Forecast for Medical Tourists Arrivals (Number), 2014 – 2018
Figure 3 1: Singapore – Medical Tourism Market (Million US$), 2003 – 2013
Figure 3 2: Singapore – Forecast for Medical Tourism Market (Million US$), 2014 – 2018
Figure 4 1: Singapore – United States Medical Tourists Arrivals (Number), 2004 – 2013
Figure 4 2: Singapore – Forecast for United States Medical Tourists Arrivals (Number), 2014 – 2018
Figure 4 3: Singapore – United States Medical Tourism Spending (Million US$), 2004 – 2013
Figure 4 4: Singapore – Forecast for United States Medical Tourism Spending (Million US$), 2014 – 2018
Figure 4 5: Singapore – Canada Medical Tourist Arrivals (Number), 2004, 2007, 2008
Figure 4 6: Singapore – Canada Medical Tourism Spending (Million US$), 2004, 2007, 2008
Figure 4 7: Singapore – Indonesia Medical Tourist Arrivals (Number), 2004 – 2013
Figure 4 8: Singapore – Forecast for Indonesia Medical Tourist Arrivals (Number), 2014 – 2018
Figure 4 9: Singapore – Indonesia Medical Tourism Spending (Million US$), 2004 – 2013
Figure 4 10: Singapore – Forecast for Indonesia Medical Tourism Spending (Million US$), 2014 – 2018
Figure 4 11: Singapore – Malaysia Medical Tourist Arrivals (Number), 2004 – 2013
Figure 4 12: Singapore – Forecast for Malaysia Medical Tourist Arrivals (Number), 2014 – 2018
Figure 4 13: Singapore – Malaysia Medical Tourism Spending (Million US$), 2004 – 2013
Figure 4 14: Singapore – Forecast for Malaysia Medical Tourism Spending (Million US$), 2014 – 2018
Figure 4 15: Singapore – Philippines Medical Tourist Arrivals (Number), 2005 – 2013
Figure 4 16: Singapore – Forecast for Philippines Medical Tourist Arrivals (Number), 2014 – 2018
Figure 4 17: Singapore – Philippines Medical Tourism Spending (Million US$), 2005 – 2013
Figure 4 18: Singapore – Forecast for Philippines Medical Tourism Spending (Million US$), 2014 – 2018
Figure 4 19: Singapore – Thailand Medical Tourist Arrivals (Number), 2004 – 2013
Figure 4 20: Singapore – Forecast for Thailand Medical Tourist Arrivals (Number), 2014 – 2018
Figure 4 21: Singapore – Thailand Medical Tourism Spending (Million US$), 2004 – 2013
Figure 4 22: Singapore – Forecast for Thailand Medical Tourism Spending (Million US$), 2014 – 2018
Figure 4 23: Singapore – China Medical Tourist Arrivals (Number), 2004 – 2013
Figure 4 24: Singapore – Forecast for China Medical Tourist Arrivals (Number), 2014 – 2018
Figure 4 25: Singapore – China Medical Tourism Spending (Million US$), 2004 – 2013
Figure 4 26: Singapore – Forecast for China Medical Tourism Spending (Million US$), 2014 – 2018
Figure 4 27: Singapore – Taiwan Medical Tourist Arrivals (Number), 2004, 2006, 2009, 2010, 2013
Figure 4 28: Singapore – Forecast for Taiwan Medical Tourist Arrivals (Number), 2014 – 2018
Figure 4 29: Singapore – Taiwan Medical Tourism Spending (Million US$), 2004, 2006, 2009, 2010, 2013
Figure 4 30: Singapore – Forecast for Taiwan Medical Tourism Spending (Million US$), 2014 – 2018
Figure 4 31: Singapore – Hong Kong Medical Tourist Arrivals (Number), 2006, 2009, 2011, 2013
Figure 4 32: Singapore – Forecast for Hong Kong Medical Tourist Arrivals (Number), 2014 – 2018
Figure 4 33: Singapore – Hong Kong Medical Tourism Spending (Million US$), 2006, 2009, 2011, 2013
Figure 4 34: Singapore – Forecast for Hong Kong Medical Tourism Spending (Million US$), 2014 – 2018
Figure 4 35: Singapore – South Korea Medical Tourist Arrivals (Number), 2004, 2009
Figure 4 36: Singapore – South Korea Medical Tourism Spending (Million US$), 2004, 2009
Figure 4 37: Singapore – India Medical Tourist Arrivals (Number), 2004 – 2013
Figure 4 38: Singapore – Forecast for India Medical Tourist Arrivals (Number), 2014 – 2018
Figure 4 39: Singapore – India Medical Tourism Spending (Million US$), 2004 – 2013
Figure 4 40: Singapore – Forecast for India Medical Tourism Spending (Million US$), 2014 – 2018
Figure 4 41: Singapore – Netherlands Medical Tourist Arrivals (Number), 2006, 2009
Figure 4 42: Singapore – Netherlands Medical Tourism Spending (Million US$), 2006, 2009
Figure 4 43: Singapore – UK Medical Tourist Arrivals (Number), 2005 – 2009, 2013
Figure 4 44: Singapore – Forecast for UK Medical Tourist Arrivals (Number), 2014 – 2018
Figure 4 45: Singapore – UK Medical Tourism Spending (Million US$), 2005 – 2009, 2013
Figure 4 46: Singapore – Forecast for UK Medical Tourism Spending (Million US$), 2014 – 2018
Figure 4 47: Singapore – Australia Medical Tourist Arrivals (Number), 2004 – 2013
Figure 4 48: Singapore – Forecast for Australia Medical Tourist Arrivals (Number), 2014 – 2018
Figure 4 49: Singapore – Australia Medical Tourism Spending (Million US$), 2004 – 2013
Figure 4 50: Singapore – Forecast for Australia Medical Tourism Spending (Million US$), 2014 – 2018
Figure 4 51: Singapore – Africa Medical Tourist Arrivals (Number), 2006 – 2013
Figure 4 52: Singapore – Forecast for Africa Medical Tourist Arrivals (Number), 2014 – 2018
Figure 4 53: Singapore – Africa Medical Tourism Spending (Million US$), 2006 – 2013
Figure 4 54: Singapore – Forecast for Africa Medical Tourism Spending (Million US$), 2014 – 2018
Figure 4 55: Singapore – Other Countries Medical Tourist Arrivals (Number), 2006 – 2013
Figure 4 56: Singapore – Forecast for Other Countries Medical Tourist Arrivals (Number), 2014 – 2018
Figure 4 57: Singapore – Other Countries Medical Tourism Spending (Million US$), 2006 – 2013
Figure 4 58: Singapore – Forecast for Other Countries Medical Tourism Spending (Million US$), 2014 – 2018 

Upcoming Reports:

Greece: market of industrial machinery for the preparation of fruits, nuts or vegetables
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the industrial machinery for the preparation of fruits, nuts or vegetables market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the industrial machinery for the preparation of fruits, nuts or vegetables market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build...
Greece: wine market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the wine market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the wine market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the main market...
Neurovascular Intervention Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Neurovascular intervention is referred to prevention, diagnosis, treatment and rehabilitation of vascular disorders of the central nervous system with minimal invasive procedures or technologies. Neurovascular disorders are normally treated through micro catheters or by emolization or recanalization of the abnormal vessels. Neurovascular intervention market is segmented on following basis: Disease condition Endovascular cerebral aneurysm Acute ischemic stroke Chronic ischemic stroke Intracranial atherosclerotic disease Device...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Order cancellations not a sign of market slump: Airbus
Jul 31, 2014  
Leading aircraft manufacturer Airbus on Wednesday said that the recent wave of order cancellations for its commercial jetliners do not mean that the market has declined. The market is still strong and single-aisle jets deals are likely to return later. A total of 225 Airbus cancellations were reported since the beginning of this year. Of these, Dubai’s Emirates Airlines alone...
Leading Australian Universities Want to Hike Fees, Enroll Fewer Students
Jul 31, 2014  
Australia’s prestigious group of top eight universities, also known as the Group of Eight (Go8), has indicated plans of increasing tuition fees while reducing the number of students they enroll, a reform-backer has predicted. These decisions could be made if the universities are deregulated .  Arguing for this decision, the chairman of Go8, and vice chancellor of the ANU, Ian...
Blackstone Invests $800 Million in Asian Oil-Based Energy Company
Jul 31, 2014  
Blackstone Energy Partners announced to invest $800 million in an Asian based energy company that is led by former industry executives.  Blackstone is popularly considered a part of the world’s largest administrator of alternatives to financial stocks and bonds. New York-based managing director, Angelo Acconcia of Blackstone Energy Partners said in an interview that Tamarind...
Bristol-Myers Squibb Posts USD 3.9 billion Revenues in 2014 Second Quarter
Jul 30, 2014  
Leading bio-pharmaceutical company Bristol-Myers Squibb has registered revenues of USD 3.9 billion in the 2014 second quarter. This marks a 4% decrease from the same period in 2013. The global revenues of the company (excluding the divested Diabetes Alliance), saw a 7% increase. In this quarter, the company’s results were underlined by steady global sales of nearly each of its...
Novartiss Simbrinza gets approval from the EU
Jul 30, 2014  
Glaucoma patients in Europe can easily obtain Novartis’ Simbrinza eye drops which are a combination of brimonidine tartrate and brinzolamide and it is without a beta-blocker. This eye drop has got the approval of the European Commission. Unlike the inefficient treatment provided by monotherapy, this eye drop aims at treating intraocular pressure or IOP in adults with ocular hypertension...